checkAd
    Recursion Pharmaceuticals Registered (A) Aktie
    8,6400
     
    USD
    +1,53 %
    +0,1300 USD
    Letzter Kurs 10.06.24 Nasdaq
    8,6200
     
    USD
    2.300 STK
    Geldkurs 10.06.24
    8,6400
     
    USD
    15.400 STK
    Briefkurs 10.06.24
    ISIN: US75629V1044 · WKN: A3CM1C · SYM: RXRX · USA

    Neueste Nachrichten

    Aktie vor "rascher Umkehr"?: Cathie Wood warnt: Nvidia braucht Unterstützung für anhaltenden Kurs-Boom(3) 
    07.06.24 · wallstreetONLINE Redaktion · NVIDIA
    Recursion to Participate in Upcoming Investor Conferences
    03.06.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
    29.05.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
    24.05.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry
    13.05.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
    09.05.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
    02.05.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion to Participate in Upcoming Investor Conferences
    01.05.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program
    30.04.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
    16.04.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion to Participate in Upcoming Investor Conference
    02.04.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion Publishes Annual Environmental, Social and Governance Report
    26.03.24 · globenewswire · Recursion Pharmaceuticals Registered (A)